The carotid artery stent market encompasses implantable devices used to treat carotid artery stenosis, a narrowing of blood vessels that supply oxygenated blood to the brain. These self-expanding or balloon-expandable stents offer a minimally invasive alternative to carotid endarterectomy, reducing procedural risks and hospital stays.

Carotid Artery Stent Market Constructed from biocompatible alloys such as nitinol or stainless steel, carotid stents deliver radial force to maintain vessel patency and prevent restenosis. The advantages include improved patient comfort, shorter recovery times, and lower complication rates, which align with current market trends favoring outpatient interventions. Rising incidences of stroke and transient ischemic attacks due to atherosclerotic plaque accumulation underscore the need for effective carotid revascularization therapies. Continuous enhancements in stent design—such as embolic protection systems and drug‐eluting coatings—are creating fresh market opportunities for device developers. As healthcare providers demand advanced solutions to manage growing patient volumes, robust market research and insights guide strategic investments in product innovation.

The carotid artery stent market is estimated to be valued at USD 621.4 Mn in 2025 and is expected to reach USD 817.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 4.00% from 2025 to 2032.

Get more insights on : Carotid Artery Stent Market

Get this Report in Japanese Language: 頸動脈ステント市場

Get this Report in Korean Language: 경동맥스텐트시장